v3.26.1
Segment and Geographic Information
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment and Geographic Information Segment and Geographic Information
The Company operates in one segment: pharmaceutical products. Its chief operating decision maker is the Chief Executive Officer, who makes operating decisions, assesses performance and allocates resources on a consolidated basis.
The primary measure of segment profitability for the Company’s operating segment is considered to be consolidated net income. Significant segment expenses reviewed by the CODM on a regular basis included within net income include cost of product sales, research and development expenses and selling, general and administrative expenses which are separately presented on the Company’s consolidated statements of operations. Other segment items within net income include interest income, interest expense, other income, net and income tax expense.
The Company’s long-lived assets are primarily located in the U.S. and China.
Net product revenues by geographic area are based upon the location of the customer, and other revenue is recorded in the jurisdiction in which the related income is expected to be sourced from. Total revenues by geographic area are presented as follows:
Three Months EndedSix Months Ended
June 30,June 30,
2026202520262025
$$$$
U.S. - total revenue914,205 694,427 1,696,460 1,261,638 
Product revenue898,616 685,395 1,664,229 1,248,743 
Other revenue15,589 9,032 32,231 12,895 
China - total revenue506,021 432,924 977,995 832,516 
Product revenue499,714 428,802 964,896 825,164 
Other revenue6,307 4,122 13,099 7,352 
Europe - total revenue208,755 152,384 402,751 270,938 
Product revenue208,403 152,314 399,724 269,212 
Other revenue352 70 3,027 1,726 
Rest of world - total revenue76,090 35,565 141,303 67,487 
Product revenue73,061 35,565 138,274 67,487 
Other revenue3,029 — 3,029 — 
Total Revenue1,705,071 1,315,300 3,218,509 2,432,579